A new Parkinson's study suggests that drugs for treating a rare genetic disorder may be effective in targeting toxic alpha-synuclein clusters in neurons.Original Article
Medical News Today: Could an existing drug halt Parkinson’s disease?
A new Parkinson's study suggests that drugs for treating a rare genetic disorder may be effective in targeting toxic alpha-synuclein clusters in neurons.